{"ok":true,"trend":{"id":1002435,"platform":"news","region":"global","key":"oral targeted anticancer medication use following high-deductible health plan enrollment","title":"Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPY2R3dlhyOGRYV3l5VXZKcFNXZVFMdmhERUZrM1h2NFVmOGlWTTU1c2RBakQzVXVjcVZEazgwQ2FkWTJlV3FtWElwV1pST2JkekJlYjhOdk9uSHcyeFg1WEtyOU1nTUhqanlkYVY1eXNic3FlbEdvRm1IUnpnOU5uTDBBVUtHOXJ2c1U2VEVWc1hLWDVzaEN3SlNIQmR5WmpiMjg0OXliRjBSWHByUUZkdjRNR3Y?oc=5","first_seen":"2026-10-04T15:55:50.326397Z","last_seen":"2026-10-05T01:31:52.700476Z","last_rank":33,"peak_rank":4,"last_volume":null,"peak_volume":0,"seen_count":8,"score":0.95625,"category_hint":"health","section":"health","category":"health","summary":"New research examines whether patients enrolled in high-deductible health plans change their use of oral targeted anticancer medications. The findings speak to a broader concern in US healthcare: whether cost-sharing requirements delay or reduce access to expensive cancer therapies, and what that means for treatment adherence and outcomes for patients facing higher out-of-pocket costs.","why":"Rising healthcare costs and insurance cost-sharing are under scrutiny, and the study touches on whether deductibles affect access to cancer treatment.","tone":"neutral","entities":["AJMC","high-deductible health plans","oral targeted anticancer medications"],"summarized_at":"2026-10-05T04:00:47.942436Z","meta":{"via":"scan","lang":"en","term":"health","source":"AJMC","published":"Sun, 04 Oct 2026 16:00:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"High-Deductible Health Plans Linked to Oral Anticancer Drug Use","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-10-04T15:55:50.326397Z","rank":4,"volume":null},{"captured_at":"2026-10-04T17:17:47.965100Z","rank":6,"volume":null},{"captured_at":"2026-10-04T18:40:50.215761Z","rank":10,"volume":null},{"captured_at":"2026-10-04T20:02:50.020827Z","rank":14,"volume":null},{"captured_at":"2026-10-04T21:24:48.563309Z","rank":8,"volume":null},{"captured_at":"2026-10-04T22:46:50.422097Z","rank":10,"volume":null},{"captured_at":"2026-10-05T00:09:31.305878Z","rank":25,"volume":null},{"captured_at":"2026-10-05T01:31:52.700476Z","rank":33,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPY2R3dlhyOGRYV3l5VXZKcFNXZVFMdmhERUZrM1h2NFVmOGlWTTU1c2RBakQzVXVjcVZEazgwQ2FkWTJlV3FtWElwV1pST2JkekJlYjhOdk9uSHcyeFg1WEtyOU1nTUhqanlkYVY1eXNic3FlbEdvRm1IUnpnOU5uTDBBVUtHOXJ2c1U2VEVWc1hLWDVzaEN3SlNIQmR5WmpiMjg0OXliRjBSWHByUUZkdjRNR3Y?oc=5","author":"AJMC","title":"Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment","snippet":null,"posted_at":"2026-10-04T13:00:00Z","likes":null}],"elsewhere":[],"window":"7d"}}